Aignostics
Latest round
- Series B
Last raised
- Oct 2024
Total raised
- $54M
Investors
- 10
About Aignostics
Founded in 2018, Aignostics GmbH is dedicated to revolutionizing precision medicine through innovative AI technologies. The company operates from its headquarters in Berlin, Germany. Co-founders Klaus Müller, Klauschen Frederick, and Viktor Matyas have combined their expertise in machine learning and biomedical analytics to provide cutting-edge solutions.Aignostics specializes in advanced products and services for precision medicine, focusing on the analysis of complex biomedical data. Their offerings include foundation models that generate embeddings for model training and custom applications for pathology workflows. Key products like the Atlas H&E-TME application enable comprehensive tumor microenvironment profiling using proprietary AI technologies.80. The company's revenue model is built around collaborations and contractual agreements with clients in the pharmaceutical and healthcare sectors, focusing on advanced machine learning services for pathology analysis and custom data solutions.00 mn, Aignostics plans to accelerate its business expansion and the development of innovative products. The company is set to enhance its existing AI solutions and explore new market opportunities, targeting expansion into North America and Asia by 2025.
Who invested in Aignostics
10 investors across 4 rounds
See all investors in Aignostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aignostics
Who invested in Aignostics?
Aignostics has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aignostics raised?
Aignostics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Aignostics last raise money?
Aignostics's most recent round on record is a Series B, in Oct 2024.
What does Aignostics do?
Founded in 2018, Aignostics GmbH is dedicated to revolutionizing precision medicine through innovative AI technologies.
Where is Aignostics headquartered?
Aignostics is headquartered in Berlin, Germany.
Which VCs invest in companies like Aignostics?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Balderton Capital back software companies at Aignostics's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Aignostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.